This inventor holds 2 USPTO granted patents. Top assignee: Merck + Co., Inc.. Active years: 2000-2004.
Company Filing History:
Years Active: 2000-2004
Title: Rey T Chern: Innovator in Bioactive Substance Delivery
Introduction
Rey T Chern is a notable inventor based in Harteyville, PA (US). He has made significant contributions to the field of bioactive substance delivery, holding 2 patents that showcase his innovative approach to solving complex problems in this area.
Latest Patents
Chern's latest patents include "Liquid polymeric compositions for controlled release of bioactive substances" and "Sulfurpentafluorophenylpyrazoles for controlling ectoparasitic." The first patent focuses on achieving controlled release of hydrophobic bioactive substances in vivo over an extended time period without bursts of drug release. This is accomplished using a liquid polymeric composition that includes a polymer such as poly(lactide-co-glycolide) copolymer in a mixture of hydrophilic and lipophilic solvents. The second patent addresses flea and tick infestations in animals, presenting sulfurpentafluorophenylpyrazoles that are highly potent against these ectoparasites. These compounds can be formulated to provide products with long duration of action and low potential for inducing vomition and other adverse reactions in treated animals.
Career Highlights
Chern is currently associated with Merck & Co., Inc., where he continues to develop innovative solutions in the pharmaceutical industry. His work has had a significant impact on improving the efficacy and safety of treatments for various conditions.
Collaborations
Throughout his career, Chern has collaborated with esteemed colleagues such as Joel R Zingerman and Jeffrey N Clark. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Rey T Chern's contributions to the field of bioactive substance delivery through his innovative patents highlight his role as a leading inventor. His work continues to influence the pharmaceutical industry and improve treatment options for various health issues.
